Mercurius Cyanatus (Hahnemann Laboratories, Inc.)


Welcome to the PulseAid listing for the Mercurius Cyanatus drug offered from Hahnemann Laboratories, Inc.. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: Hahnemann Laboratories, Inc.
NON-PROPRIETARY NAME: Mercurius Cyanatus
SUBSTANCE NAME: MERCURIC CYANIDE
TYPE: HUMAN OTC DRUG
PHARMA CLASS:
ROUTE: BUCCAL; ORAL; SUBLINGUAL
DOSAGE FORM: PELLET
MARKETING CATEGORY NAME: UNAPPROVED HOMEOPATHIC
START MARKETING DATE: 2017-05-04
END MARKETING DATE: 0000-00-00


Mercurius Cyanatus HUMAN OTC DRUG Details:

Item DescriptionMercurius Cyanatus from Hahnemann Laboratories, Inc.
LABELER NAME: Hahnemann Laboratories, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 30([hp_C]/[hp_C])
START MARKETING DATE: 2017-05-04
END MARKETING DATE: 0000-00-00
PRODUCT ID: 63545-683_4eb9441b-27c7-1b8f-e054-00144ff88e88
PRODUCT NDC: 63545-683
APPLICATION NUMBER:

Other MERCURIC CYANIDE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Hahnemann Laboratories, Inc.Mercurius Cyanatus
Paramesh Banerji Life Sciences LLCMercurius cyanatus 200C
Uriel Pharmacy Inc.Mercurius cyanatus 8
Washington Homeopathic ProductsMercurius cyanatus